A practical reference on 内毒素: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-03-02. Anything still debated is marked as such rather than presented as settled.
Insulin-like growth factor 1 is produced largely in the liver in response to growth hormone signaling. Its concentration shifts over days rather than minutes, which makes it practical for tracking changes across a study period. Interpretation still depends on age, nutritional status, and concurrent illness, all of which independently affect the marker. Reference ranges are therefore stratified, and comparisons are usually made within an individual over time rather than against a single population threshold.
Assays for these markers differ in calibration and antibody specificity, so results from different platforms are not always interchangeable. Reported values can shift when a laboratory changes method, even without any biological change. Studies that span long periods or multiple sites often need cross-validation of assays. This methodological variability is a recognized limitation when comparing findings across published reports, and it remains a topic of ongoing standardization work.
Measuring the effect of a growth hormone-releasing hormone analogue requires markers that reflect pituitary output rather than the peptide itself. The two most frequently used are growth hormone and insulin-like growth factor 1. Growth hormone fluctuates sharply across the day and responds to sleep, stress, and meals, so isolated readings can be difficult to interpret. Insulin-like growth factor 1 changes more slowly and is often treated as the more stable integrated marker of axis activity.
作用位置在垂体前叶。tesamorelin 与 GHRH 受体结合后激活腺苷酸环化酶，升高细胞内 cAMP，再经蛋白激酶 A 通路促进生长激素的合成与释放。由于它作用于内源调控节点，生长激素仍以脉冲方式分泌，而不是被持续抬升到固定水平。生长激素随后在肝脏等组织诱导胰岛素样生长因子 1 产生，构成完整的生长激素轴响应。
研究背景集中在特定人群的体成分改变，尤其是与脂肪分布异常相关的内脏脂肪堆积。不同地区对它的监管状态与获批适应症并不一致，部分市场仅限特定诊断人群使用。在一般人群中的长期效应、与其他激素的相互作用以及停药后的维持情况仍属开放问题，现有数据不足以给出普遍结论。
tesamorelin 是一种人工合成的四十四肽，序列与内源性生长激素释放激素（GHRH）的 1-44 片段一致，区别在于 N 端加接了一个反式-3-己烯酰基。该修饰抑制二肽基肽酶 IV 的快速切割，从而延长分子在循环中的存留时间。作为肽类分子，它难以经胃肠道吸收，文献中讨论的均是注射途径。分类上通常把它归为 GHRH 类似物，以区别于生长激素本身。
| Property | Value | Notes |
|---|---|---|
| Primary marker | Insulin-like growth factor 1 | Slow-changing integrated indicator of axis activity |
| Secondary marker | Growth hormone | Pulsatile; requires repeated or timed sampling |
| Typical analytical method | Immunoassay | Antibody-based quantification in serum |
| Common sample matrix | Serum | Collected under standardized conditions |
| Key interpretation factor | Age-stratified reference ranges | Baseline marker concentrations shift with age |
纯度与身份确认依赖色谱与质谱的组合。反相高效液相色谱在 214 nm 紫外检测下分离主峰与相关杂质，给出纯度百分比与保留时间；电喷雾或基质辅助激光解吸电离质谱提供分子量，用于确认 N 端修饰是否完整。序列层面可通过肽图或氨基酸分析验证。含量测定常用紫外吸收法或氮元素分析，不同方法之间需要做交叉校验。
冻干粉末一般在 -20°C 或更低温度、干燥避光条件下保存，可维持较长时间的稳定。复溶后稳定性明显下降，溶液中的肽链易发生水解、氧化与聚集，通常需冷藏并在短期内用完。反复冻融会加速聚集与降解，建议分装后单次使用。缓冲体系的 pH 与离子强度同样影响聚集速率，需要按具体实验条件验证。
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin binds the growth hormone–releasing hormone receptor on pituitary somatotroph cells. The receptor signals through the Gs protein, raising intracellular cAMP and activating protein kinase A. That cascade triggers release of stored growth hormone in pulses rather than a steady stream. Because the drug acts at the receptor that normally controls this process, its effect depends on the body's own signaling architecture rather than on a synthetic pathway. The resulting hormone profile reflects the timing of each pulse, not only its size.
Measured responses usually involve growth hormone and insulin-like growth factor 1, known as IGF-1. Growth hormone rises in bursts and is difficult to sample reliably, while IGF-1 shifts more slowly and can be assessed from a single blood draw. Studies therefore treat IGF-1 as the more practical pharmacodynamic marker. Both are indirect, showing that the receptor was engaged rather than that the peptide reached a particular concentration. Direct exposure measurement requires an assay aimed at the molecule itself.
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.
It is not true that more people have died from the COVID-19 vaccine than from COVID-19 itself. Severe adverse reactions from the vaccine are rare, and an "exceedingly small" number of deaths have been caused by the vaccine. Meanwhile, the death toll from the disease itself is in the millions. Tuberculosis is not purely a disease of the lungs that has symptoms of coughing. It may instead infect a wide range of other organs in the body. Cancer cannot be treated by restricting food intake and so supposedly "starving" tumors. Rather, the health of people with cancer is best served by maintaining a healthy diet. The common cold and the common flu are caused by viruses, not exposure to cold temperatures. However, low temperatures may somewhat weaken the immune system, and someone already infected with a cold or influenza virus but showing no symptoms can become symptomatic after they are exposed to low temperatures. Viruses are more likely to spread during the winter for a variety of reasons such as dry air, less air circulation in homes, people spending more time indoors, and lower vitamin D levels in humans. Antibiotics will not cure a cold; they treat bacterial diseases and are ineffectual against viruses. However, they are sometimes prescribed to prevent or treat secondary infections. There is little to no evidence that any illnesses are curable through essential oils or aromatherapy, and fish oil has not been shown to cure dementia.
=== 1960s–1990s === In 1960, Tom Monaghan and his brother, Jim, took over the operation of DomiNick's, an existing location of a small pizza restaurant chain that had been owned by Dominick DeVarti, at 507 Cross Street (now 301 West Cross Street) in Ypsilanti, Michigan, near Eastern Michigan University. The deal was secured by a $500 down payment, after which the brothers borrowed $900 to pay for the store. The brothers planned to split the work hours evenly, but Jim did not want to quit his job as a full-time postman to keep up with the demands of the new business. Within eight months, Jim traded his half of the business to Tom for the Volkswagen Beetle they used for pizza deliveries. By 1965, Tom Monaghan had purchased two additional pizzerias; he now had a total of three locations in the same county. Monaghan wanted the stores to share the same branding, but the original owner forbade him from using the DomiNick's name. One day, an employee, Jim Kennedy, returned from a pizza delivery and suggested the name "Domino's". Monaghan immediately loved the idea and officially renamed the business to Domino's Pizza, Inc. in 1965. The company logo originally had three dots (🁀), representing the three stores in 1965. Monaghan planned to add a new dot with the addition of every new store, but this idea quickly faded, as Domino's experienced rapid growth. Domino's Pizza opened its first franchise location in 1967 and by 1978, the company had expanded to 200 stores.
== Safety considerations == Because microbial therapeutics involve living organisms, safety is a key consideration in their development and use. Potential risks include uncontrolled growth of the microorganisms, unwanted interactions with the existing microbiome, or unexpected immune reactions. There are also concerns about the transfer of genetic material between microorganisms, which could affect other microbes in the body or the environment. To reduce these risks, researchers use multiple safety strategies. One approach is biocontainment, which involves designing microorganisms so they can survive only under specific conditions. For example, engineered microbes may depend on nutrients that are only available during treatment or be programmed to self-destruct after a certain period of time. These strategies help limit how long the microorganisms persist and reduce the risk of unintended spread. Additional safety measures include careful selection of microbial strains, extensive testing in laboratory and animal studies, and controlled clinical trials in humans. Regulatory agencies require thorough safety evaluations before microbial therapeutics can be approved for clinical use, with the goal of ensuring that these treatments are both effective and safe.
== Early life and education == In 1974, Eaton graduated from Montana State University with a Bachelor of Science in Pre-Medical Sciences. Under the guidance of Curtis Klaassen and John Doull, he earned a Ph.D. in pharmacology and toxicology at the University of Kansas Medical Center in 1978. In 1979, he joined the faculty at the University of Washington after completing a postdoctoral fellowship in toxicology at the same institution after earning his Ph.D.
Sources: en.wikipedia.org
==== Oral isotretinoin ==== Oral isotretinoin (retinoic acid isomer) is recommended for treating treatment resistant acne, acne that can lead to scarring, and acne that is associated with psychosocial distress. It is approved by the FDA for treating severe acne vulgaris that is resistant to other treatment options. Isotretinoin is a known teratogen, with an estimated 20–35% risk of physical birth defects to infants that are exposed to isotretinoin in utero, including numerous congenital defects such as craniofacial defects, cardiovascular and neurological malformations or thymic disorders. Neurocognitive impairments in the absence of any physical defects has been established to be 30–60%. For these reasons, physician- and patient-education programs were initiated, recommending that for women of child-bearing age, contraception be initiated a month before starting oral (or topical) isotretinoin, and continue for a month after treatment ended. In the US, isotretinoin was released to the market in 1982 as a revolutionary treatment for severe and refractory acne vulgaris. It was shown that a dose of 0.5–1.0 mg/kg body weight/day is enough to produce a reduction in sebum excretion by 90% within a month or two, but the recommended treatment duration is 4 to 6 months. The mechanism by which orally consumed retinoic acid (RA), as all-trans-tretinoin or 13-cis-isotretinoin improves facial skin health is thought to be by switching on genes and differentiating keratinocytes (immature skin cells) into mature epidermal cells.
Physicians have been advised to help patients interested in looksmaxxing to distinguish between safe beauty practices and harmful practices, suggesting to patients to only conduct looksmaxxing practices when done in a medically viable manner. Clavicular's system of rating looksmaxxing that he promotes in interviews and on social media is the PSL scale, which gives men a numerical rating then sorts men into three tiers: "subhuman", "normie", and "Chad". In her New Yorker criticism, journalist Becca Rothfeld explains, "The moral objections to looksmaxxing are numerous, severe, and obvious. A system that designates any person as 'subhuman' is beneath contempt, and that's to say nothing of the racial slurs to which looksmaxxing stalwarts help themselves regularly." She also cites a recent interview in which Clavicular "approvingly notes that Brad Pitt 'mogs' Mother Teresa". While its encouragement for men to care about their health and fitness can be seen as a positive, looksmaxxing overall is seen as demoralising to men, especially the young. A study published in the National Library of Medicine argues that looksmaxxing promotes a hegemonic masculine gaze on male bodies. Hegemonic masculinity is a social concept developed by R. W. Connell that defines the ideal form of dominant and physically attractive male bodies, legitimizes sexism, and reinforces patriarchy. The study's findings support its argument, and proves that the looksmaxxing community revolves around male supremacy and hegemonic masculinity.
All committees have an allotted budget to which they must adhere. Any committee may start a project. If a project's spending becomes too much for a committee to continue funding, it must take the issue to the Project Committee. The project committee either increases the budget or decides on an external funding plan. The Bureau and Executive Committee oversee operations of the other committees.
Sources: en.wikipedia.org
It varies slowly and reflects cumulative axis activity rather than momentary secretion. Growth hormone is released in pulses affected by sleep, stress, and meals, making single readings hard to interpret. The slower marker gives a more stable picture across a study period.
Assay calibration and antibody specificity differ between platforms, so identical samples can yield different numbers. A method change within one laboratory can shift results without any biological change. Cross-validation is often needed for multi-site work.
They capture only one moment in a pulsatile pattern and are strongly influenced by recent activity and meals. Repeated sampling or overnight profiles provide a more representative view. Provocative testing is an alternative when a dynamic response is of interest.
tesamorelin 属 GHRH 类似物，作用于垂体受体以促进内源生长激素释放；生长激素本身是直接补充的外源激素。两者在给药逻辑、作用位点和反馈调控路径上并不相同。